Compound Detail
CHEMBL349294
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL349294 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | RCSLUNOLLUVOOG-LLVKDONJSA-N |
1
Targets
2
Activities
1
Assay Types
0
PK Parameters
2
Publications
0
Known Names
Molecular Properties
321.9
MW (Da)
4.15
ALogP
4
HBA
1
HBD
21.1
PSA (Ų)
0.66
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 7.37
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| MT4 CHEMBL388 | IC50 | 7.37 | 6.89 | 43.0 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| MT4 | IC50 | = | 43.0 | nM | 7.37 | Effective concentration of compound required to achieve 50% protection of MT-4 c... | 7877143 |
| MT4 | IC50 | = | 390.0 | nM | 6.41 | Ability to block replication of HIV-1 virus in mock infected MT-4 cells | 1956037 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 7877143 | 10.1021/jm00005a005 | MT4 | 1 |
| 1956037 | 10.1021/jm00115a007 | MT4 | 1 |
Data from ChEMBL 36 via Core Engine